Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis

R Oren1, Y Maaravi, F Karmeli

  • 1Department of Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.

Alimentary Pharmacology & Therapeutics
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unleashing the power of anti-HER2 therapies in metastatic colorectal cancer: paving the way for a brighter future.

ESMO gastrointestinal oncology·2026
Same author

Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data.

ESMO open·2024
Same author

A new electron diffraction approach for structure refinement applied to Ca<sub>3</sub>Mn<sub>2</sub>O<sub>7</sub>.

Acta crystallographica. Section A, Foundations and advances·2021
Same author

A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer.

Familial cancer·2021
Same author

A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire.

Clinics and research in hepatology and gastroenterology·2021
Same author

Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy.

International journal of cardiology·2021
Same journal

Editorial: Non-Selective Beta-Blockers in Decompensated Cirrhosis-More Friends Than Foes.

Alimentary pharmacology & therapeutics·2026
Same journal

Letter: Reconciling Histological Fibrosis Improvement With Magnetic Resonance Elastography After Sleeve Gastrectomy.

Alimentary pharmacology & therapeutics·2026
Same journal

Letter on: Pre-Emptive Initiation of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema Improves Outcomes: A Randomized Controlled Trial.

Alimentary pharmacology & therapeutics·2026
Same journal

Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis.

Alimentary pharmacology & therapeutics·2026
Same journal

Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine.

Alimentary pharmacology & therapeutics·2026
Same journal

Elobixibat Versus Prucalopride in Functional Constipation: A Prospective Comparative Effectiveness Study.

Alimentary pharmacology & therapeutics·2026
See all related articles

Anti-thyroid drugs methimazole and propylthiouracil significantly reduced inflammation and damage in a rat model of colitis. These findings suggest potential therapeutic benefits for autoimmune gastrointestinal diseases.

Area of Science:

  • Immunology
  • Gastroenterology
  • Pharmacology

Background:

  • Methimazole, an anti-thyroid drug, shows promise in treating autoimmune diseases like systemic lupus erythematosus.
  • Hypothyroidism, induced by anti-thyroid drugs, alters immunological markers, including T-cell activity and cytokine receptors.
  • Experimental colitis serves as a model to investigate the therapeutic potential of anti-thyroid drugs in inflammatory bowel disease.

Purpose of the Study:

  • To investigate the effects of methimazole and propylthiouracil on experimental colitis in a rat model.
  • To evaluate the impact of these drugs on inflammatory markers and tissue damage in the colon.

Main Methods:

  • Colitis was induced in rats using intracolonic administration of trinitrobenzene sulphonic acid (TNB).

Related Experiment Videos

  • Rats were pre-treated with methimazole (0.04%) or propylthiouracil (0.01%) in drinking water.
  • Macroscopic and microscopic damage, colon weight, and myeloperoxidase (MPO) activity were assessed at 48 hours and 7 days post-induction.

    • Main Results:

    • Pre-treatment with methimazole or propylthiouracil significantly reduced macroscopic and microscopic mucosal damage in the colon.
    • Both drugs led to a significant decrease in colonic weight and myeloperoxidase (MPO) activity, indicating reduced inflammation.
    • Treated rats exhibited elevated thyroid-stimulating hormone (TSH) levels, confirming induced hypothyroidism.

    Conclusions:

    • Methimazole and propylthiouracil demonstrate significant efficacy in reducing mucosal damage and colonic weight in a rat model of experimental colitis.
    • The findings suggest a potential therapeutic role for these anti-thyroid drugs in managing inflammatory bowel diseases.
    • Further research is warranted to elucidate the precise mechanisms underlying the observed therapeutic effects.